On April 24, 2020 (early in the COVID-19 pandemic), a group of…

Question Answered step-by-step On April 24, 2020 (early in the COVID-19 pandemic), a group of… On April 24, 2020 (early in the COVID-19 pandemic), a group of scientists released data (Links to an external site.) about the accuracy of COVID-19 lateral flow assays that are currently on the market (these are rapid antibody tests to determine if a patient is producing antibodies against the virus).The data shown below is from their study. In this part of the study they tested 108 patients that had tested negative for COVID-19 using the PCR-based test.Each company’s test is clustered together in different rows. The light green dots represent patients that tested negative with the serological test. The dark blue dots represent patients that tested positive. The yellow dots indicate a patient whose sample was not tested with that brand’s test. The last row (In-house ELISA is NOT a lateral flow assay. It is a more sensitive test and is used as the control for this experiment). Take a look at the data and answer the questions below:What does it mean for a person to have a positive antibody test?Which company had the highest false positive rate? What was the rate of false positives for this company (show your calculations)?If you were advising our governor where to buy tests for large-scale testing, what are the top three vendors you would recommend? Why? Biology Science Microbiology BIOSC MISC Share QuestionEmailCopy link Comments (0)